Last Updated: 15 Sep 2024
Executive Summary
Kenvue Inc. (KVUE) is a global consumer health company with a market capitalization of $44.8 billion. The company's financial performance has been strong, with revenue and earnings growing steadily in recent years. Kenvue's stock price has also performed well, outperforming the broader market over the past year. Analysts are generally positive on the company's prospects, with a consensus price target of $22.15.
Company Overview
Kenvue Inc. is a consumer health company that develops, manufactures, and markets a wide range of personal care products. The company's products include skincare, haircare, and oral care products. Kenvue sells its products through a variety of channels, including mass retailers, drugstores, and online retailers.
Fundamental Analysis
Kenvue's financial performance has been strong in recent years. The company's revenue has grown from $13.5 billion in 2020 to $15.5 billion in 2023. Net income has also grown steadily, from $2.5 billion in 2020 to $3.6 billion in 2023.
Kenvue's profitability metrics are also strong. The company's gross profit margin has been around 55% in recent years, and its operating profit margin has been around 20%. Kenvue's return on equity has also been strong, averaging around 15% in recent years.
Technical Analysis
Kenvue's stock price has performed well over the past year, outperforming the broader market. The stock price has traded in a range between $17.11 and $23.47 over the past 52 weeks. The stock price is currently trading at $23.39, which is near the high end of its recent trading range.
The technical indicators are mixed for Kenvue. The relative strength index (RSI) is above 70, which indicates that the stock is overbought. However, the moving average convergence divergence (MACD) is above its signal line, which indicates that the stock is in a bullish trend.
Short Term Outlook
The short-term outlook for Kenvue is mixed. The stock price is currently trading near the high end of its recent trading range, and the RSI is above 70. This suggests that the stock may be due for a pullback. However, the MACD is above its signal line, which indicates that the stock is in a bullish trend.
Long Term Outlook
The long-term outlook for Kenvue is positive. The company's financial performance has been strong in recent years, and the company is well-positioned to continue to grow in the future. Kenvue's products are in high demand, and the company has a strong track record of innovation.
Analyst Recommendations
Analysts are generally positive on Kenvue's prospects. The consensus price target for the stock is $22.15, which represents a potential upside of 5.7% from the current price. One analyst has a strong buy rating on the stock, six analysts have a buy rating, eight analysts have a hold rating, and one analyst has a strong sell rating.
